Skip to main content
SpringerLink
Log in

Relevance of Precision Medicine in Public Health Genomics and Global Health Genomics

  • Chapter
  • First Online:
Global Perspectives on Precision Medicine

Part of the book series: Advancing Global Bioethics ((AGBIO,volume 19))

Abstract

Precision Medicine (PM) is anticipated to have significant impact on individual health, public health and global health. With advances in sequencing technology, PM is anticipated to have the capacity of predicting health risks and outcomes and improve population health by using genomics and big data, with the aim to provide the right intervention to the right population at the right time – with the goal of improving health for all. In terms of global health, genomics will play a significant role in the prevention and treatment of emerging and reemerging infectious diseases, and prevention and containment of acute and chronic epidemics, and even global pandemics (influenza, tuberculosis, HIV, and COVID-19). Predicting the response to drug treatments, increasing efficacy and avoiding ADRs in public health is also a positive role of PM. However, opponents are worried about the ethical and social concerns, such as the fear of raising the 10/90 gap between developed and developing countries due to PM. With the goal of looking at PM in public health and global health genomics, this chapter will focus on the relevance of PM in the developed and developing countries, while discussing the anticipated ethical and social issues with recommendations to address the concerns.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Acharya, Tara, et al. 2004. Strengthening the role of genomics in Global Health. PLoS Medicine 1 (3): 195–197.

    Article  Google Scholar 

  • Adedokun, B.O., et al. 2016. Building local capacity for genomics research in Africa: Recommendations from analysis of publications in Sub-Saharan Africa from 2004 to 2013. Global Health Action 9 (1): 1–10.

    Article  Google Scholar 

  • Aicardi, C., et al. 2016. Emerging ethical issues regarding digital health data. On the world medical association draft declaration on ethical considerations regarding health databases and biobanks. Croatian Medical Journal 57: 207–213.

    Article  Google Scholar 

  • Alffenaar, Jan-Willem C., Onno W. Akkerman, Hannah Yejin Kim, Simon Tiberi, and Giovanni Battista Migliori. 2020. Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use? International Journal of Infectious Diseases 92S: S5–S9.

    Article  Google Scholar 

  • American Heart Association. 2017. Cardiovascular disease: A costly burden for American projections through 2035. 1–16. https://www.heart.org/idc/groups/heart-public/@wcm/@adv/documents/downloadable/ucm_491543.pdf.

  • Au, R., M. Ritchie, S. Hardy, T.F.A. Ang, and H. Lin. 2019. Aging well: Using precision to drive down costs and increase health quality. Advanced Geriatric Medical Resource 1: e190003.

    Google Scholar 

  • Badzek, L., Mark Henaghan, Martha Turner, and Rita Monsen. 2013. Ethical, legal, and social issues in the translation of genomics into health care. Journal of Nursing Scholarship 45 (1): 15–24.

    Article  Google Scholar 

  • Bancroft, Elizabeth K. 2013. How advances in genomics are changing patient care. Nursing Clinics of North America 48: 557–569.

    Article  Google Scholar 

  • Bartz, D., et al. 2020. Clinical advances in sex- and gender-informed medicine to improve the health of all: A review. JAMA Internal Medicine 180 (4): 574–583.

    Article  Google Scholar 

  • Baynam, G., et al. 2017. Improved diagnosis and care for rare diseases through implementation of precision public health framework. Advances in Experimental Medicine and Biology 1031: 55–94.

    Article  Google Scholar 

  • Belsky, D.W., Terrie E. Moffitt, and Avshalom Caspi. 2013. Genetics in population health science: Strategies and opportunities. American Journal of Public Health 103 (S1): S73–S83.

    Article  Google Scholar 

  • Blix, A. 2014. Personalized medicine, genomics, and pharmacogenomics: A primer for nurses. Clinical Journal of Oncology Nursing 18 (4): 437–441.

    Article  Google Scholar 

  • Boccia, S. 2014. Why is personalized medicine relevant to public health? European Journal of Public Health 24 (3): 349–350.

    Article  Google Scholar 

  • Bonham, V.L., and Sarah Knerr. 2008. Social and ethical implications of genomics, race, ethnicity and health inequities. Seminars in Oncology Nursing 24 (4): 254–261.

    Article  Google Scholar 

  • Brand, Angela, et al. 2008. The impact of genetics and genomics on public health. European Journal of Human Genetics 16: 5–13.

    Article  Google Scholar 

  • Burke, Wylie, et al. 2010. Extending the reach of public health genomics: What should be the agenda for public health in an era of genome-based and “personalized” medicine? Genetics in Medicine 12 (12): 785–791.

    Article  Google Scholar 

  • Burke, W., et al. 2014. Essential elements of personalized medicine. Urologic Oncology 32 (2): 193–197.

    Article  Google Scholar 

  • Chadwell, Katherine. 2013. Clinical practice on the horizon: Personalized medicine. Clinical Nurse Specialist 27: 36–43.

    Article  Google Scholar 

  • Chakaya, J., et al. 2021. Global tuberculosis report 2020 – Reflections on the global TB burden, treatment and prevention efforts. International Journal of Infectious Diseases 113: 1–6.

    Article  Google Scholar 

  • Cholerton, B., et al. 2016. Precision medicine: Clarity for the complexity of dementia. The American Journal of Pathology 186 (3): 500–506.

    Article  Google Scholar 

  • Cirillo, D., et al. 2020. Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare. Nature Partner Journals, Digital Medicine 3 (81): 1–11.

    Google Scholar 

  • Clayton, E.W. 2003. Genomic medicine: Ethical, legal, and social implications of genomic medicine. New England Journal of Medicine 349 (6): 562–624.

    Article  Google Scholar 

  • Conley, John M., Adam K. Doerr, and Daniel B. Vorhaus. 2010. Enabling responsible public genomics. Journal of Law-Medicine 20 (2): 325–385.

    Google Scholar 

  • Cox, H., Jennifer Hughes, John Black, and Mark P. Nicol. 2018. Precision medicine for drug-resistant tuberculosis in high-burden countries: Is individualised treatment desirable and feasible? Lancet Infect Diseases 18: 1–6.

    Article  Google Scholar 

  • Davies, S. 2010. Global politics of health. Cambridge: Polity Press.

    Google Scholar 

  • Dickenson, D. 2013. Me medicine vs we medicine: Reclaiming biotechnology for the common good. New York: Columbia University Press.

    Book  Google Scholar 

  • Divine, M. 2021. How WHO is fighting congenital anomalies. The Borgen Project. Retrieved from: How the World Health Organization is Fighting Congenital Anomalies – The Borgen Project.

    Google Scholar 

  • Drake, T.M., Stephen R. Knight, Ewen M. Harrison, and Kjetil Søreide. 2018. Global inequities in precision medicine and molecular cancer research. Frontiers in Oncology 8 (346): 1–12.

    Google Scholar 

  • Ebomoyi, E.W., and J.I. Ebomoyi. 2012. Human genome sequencing technologies, the medical, public health and economic implications in the industrialised G-8 nations. International Journal of Medical Engineering and Informatics 4 (1): 97–107.

    Article  Google Scholar 

  • Elfein, J. 2021. Number of deaths caused by selected communicable diseases annually worldwide as of 2019. Statista. Retrieved from: https://www.statista.com/statistics/282715/deaths-from-communicable-diseases-worldwide/.

  • Etchegary, H., et al. 2013. Consulting the community: Public expectations and attitudes about genetics research. European Journal of Human Genetics 21 (12): 1338–1343.

    Article  Google Scholar 

  • Foster, M.W., et al. 2006. The routinisation of genomics and genetics: Implications for ethical practices. Journal of Medical Ethics 32 (11): 635–638.

    Article  Google Scholar 

  • Geller, G., et al. 2014. Genomics and infectious disease: A call to identify the ethical, legal and social implications for public health and clinical practice. Genome Medicine 6 (106): 1–13.

    Google Scholar 

  • Gerard, S., Maxine Hayes, and Mark A. Rothstein. 2002. On the edge of tomorrow: Fitting genomics into public health policy. Journal of Law, Medicine & Ethics 30 (3): 173.

    Google Scholar 

  • Gibbon, S. 2009. Genomics as public health? Community genetics and the challenge of personalised medicine in Cuba. Anthropology & Medicine 16 (2): 131–146.

    Article  Google Scholar 

  • Gibbon, S., et al. 2018. Genomics and genetic medicine: Pathways to global health? Anthropology and Medicine 25 (1): 1–10.

    Article  Google Scholar 

  • Global Forum for Health Research. 2002. Global Forum for Health Research: The 10/90 Report on Health Research 2001–2002. Geneva: Global Forum for Health Research.

    Google Scholar 

  • Gostin, Lawrence O., and Fund Milbank Memorial. 2010. Public health law and ethics: A reader. Berkeley: University of California Press.

    Google Scholar 

  • Green, R.F., W.D. Dotson, S. Bowen, K. Kolor, and M.J. Khoury. 2015. Genomics in public health: Perspective from the Office of Public Health Genomics at the Centers for Disease Control and Prevention (CDC). Healthcare (Basel) 3 (3): 830–837.

    Article  Google Scholar 

  • Groop, L., Petter Storm, and Anders Rosengren. 2014. Can genetics improve precision of therapy in diabetes? Trends in Endocrinology and Metabolism: TEM 25 (9): 440–443.

    Article  Google Scholar 

  • Hall, W.D., et al. 2010. Being more realistic about the public health impact of genomic medicine. PLoS Medicine 7: 1–4.

    Article  Google Scholar 

  • Haque, M., Tariqul Islam, Massimo Sartelli, Adnan Abdullah, and Sameer Dhingra. 2020. Prospects and challenges of precision medicine in lower- and middle-income countries: A brief overview. Bangladesh Journal of Medical Science 19 (1): 1–17.

    Article  Google Scholar 

  • Hernandez, Lyla, ed. 2005. Implications of genomics for public health: Workshop summary. Washington, DC: National Academies Press. Retrieved from: http://www.healthdata.org/news-release/global-health-funding-reaches-new-high-funding-priorities-shift.

    Google Scholar 

  • Institute for Health Metrics and Evaluation. IHME. 2018. Global spending on health is expected to increase to $18.28 trillion worldwide by 2040: New study encourages policymakers to prevent large health financing gaps. ScienceDaily. www.sciencedaily.com/releases/2016/04/160414095539.htm. Accessed 27 Aug 2018.

  • Inzaule, Seth C., Sofonias K. Tessema, Yenew Kebede, Ahmed E. Ogwell Ouma, John N. Nkengasong, et al. 2021. Genomic-informed pathogen surveillance in Africa: Opportunities and challenges. Lancet Infectious Disease 21: 1–9.

    Article  Google Scholar 

  • Iskandar, K., et al. 2021. Surveillance of antimicrobial resistance in low- and middle-income countries: A scattered picture. Antimicrobial Resistance and Infection Control 10 (63): 1–19.

    Google Scholar 

  • Jaja, C., Robert Gibson, and Shirley Quarles. 2013. Advancing genomic research and reducing health disparities: What can nurse scholars do? Journal of Nursing Scholarship 45 (2): 202–209.

    Article  Google Scholar 

  • Johnson, S.B., I. Slade, A. Giubilini, et al. 2020. Rethinking the ethical principles of genomic medicine services. European Journal of Human Genetics 28: 147–154.

    Article  Google Scholar 

  • Khoury, M.J. 2011. Public health genomics: The end of the beginning. Genetics in Medicine 13 (3): 206–209.

    Article  Google Scholar 

  • Khoury, M., and K. Holt. 2021. The impact of genomics on precision public health: Beyond the pandemic. Genome Medicine 13 (67): 1–4.

    Google Scholar 

  • Kittles, R. 2012. Genes and environments: Moving toward personalized medicine in the context of health disparities. Ethnicity & Disease 22 (3): S1-43–S1-46.

    Google Scholar 

  • Lange, C., et al. 2020. Perspective for precision medicine for tuberculosis. Frontiers of Immunology 11 (566608): 1–9.

    Google Scholar 

  • Lonardo, A., J.P. Arab, and M. Arrese. 2021. Perspectives on precision medicine approaches to NAFLD diagnosis and management. Advances in Therapy 38: 2130–2158.

    Article  Google Scholar 

  • Manamperi, Aresha. 2008. Current developments in genomics and personalized health care: Impact on public health. Asia-Pacific Journal of Public Health 20 (3): 242–250.

    Article  Google Scholar 

  • Marzuillo, C., et al. 2014. Are public health professionals prepared for public health genomics? A cross-sectional survey in Italy. BMC Health Services Research 14 (1): 415–432.

    Article  Google Scholar 

  • McClellan, K.A., et al. 2013. Personalized medicine and access to health care: Potential for inequitable access? European Journal of Human Genetics 21: 143–147.

    Article  Google Scholar 

  • Mehta, U.C. 2011. Pharmacovigilance: The devastating consequences of not thinking about adverse drug reactions. CME 29 (6): 247–251.

    Google Scholar 

  • Mette, L., et al. 2012. Pharmacogenomics and public health: Implementing ‘populationalized’ medicine. Pharmacogenomics 13 (7): 803–813.

    Article  Google Scholar 

  • Mulder, N., et al. 2018. H3Africa: Current perspectives. Pharmacogenomics and Personalized Medicine 11: 59–66.

    Article  Google Scholar 

  • Murff, H.J., et al. 2004. The impact of family history of diabetes on glucose testing and counseling behavior in primary care. Diabetes Care 27 (9): 2247–2248.

    Article  Google Scholar 

  • Murray, C. 2013. Global health funding reaches new high as funding priorities shift. Institute for Health Metrics and Evaluation.

    Google Scholar 

  • National Institute of Health (NIH). 2017. BRCA mutations: Cancer risk and genetic testing. https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet#q11. Accessed 23 July 2018.

  • Newnham, J.P., et al. 2017. Applying precision public health to prevent preterm birth. Frontiers in Public Health. Retrieved from: https://www.frontiersin.org/articles/10.3389/fpubh.2017.00066/full.

    Book  Google Scholar 

  • Nishi, Akihiro, et al. 2016. Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Review of Molecular Diagnostics 16 (1): 1–14.

    Article  Google Scholar 

  • Ojha, Rohit P., and Raymond Thertulien. 2005. Health care policy issues as a result of the genetic revolution: Implications for public health. American Journal of Public Health 95: 385–388.

    Article  Google Scholar 

  • Prince, Anya E.R. 2015. Automatic placement of genomic research results in medical records: Do researchers have a duty? Should participants have a choice? Privacy, Laws and International Biobank Research 43: 827–842.

    Google Scholar 

  • Ratcliff, Chelsea L., Kimberly A. Kaphingst, and Jakob D. Jensen. 2017. When personal feels invasive: Foreseeing challenges in precision medicine communication. Journal of Health Communication 23: 1–9.

    Google Scholar 

  • Rehm, Heidi L. 2017. Evolving health care through personal genomics. Nature Reviews Genetics 18 (4): 259–267. Retrieved from: https://www.genome.gov/about-genomics/policy-issues/Informed-Consent.

    Article  Google Scholar 

  • Roberts, D.E. 2008. Is Race-based medicine good for us?: African American approaches to race, biomedicine, and equality. Journal of Law, Medicine & Ethics 36 (3): 537–545.

    Article  Google Scholar 

  • Roberts, J. Scott, et al. 2014. Emerging issues in public health genomics. Annual Review of Genomics and Human Genetics 15: 461–480.

    Article  Google Scholar 

  • Ryan, L., M. Hay, M.J. Huetalman, and D. Audrey. 2019. Precision aging: Applying precision medicine to the field of cognitive aging. Frontiers in Aging Neuroscience 11: 20.

    Article  Google Scholar 

  • Sahlin, Nils-Eric, and Göran Hermerén. 2012. Personalised, predictive and preventive medicine: A decision theoretic perspective. Journal of Risk Research 15 (5): 453–457.

    Article  Google Scholar 

  • Shawky, R.M., Nour El Din, and M. Sahar. 2010. Genomics in health and disease. Egyptian Journal of Medical Human Genetics 11 (1): 11–16.

    Article  Google Scholar 

  • Shchory, M.P., Lee H. Goldstein, Lidia Arcavi, Renata Shihmanter, Matitiahu Berkovitch, and Amalia Levy. 2020. Increasing adverse drug reaction reporting—How can we do better? PLoS One 15: 1–15.

    Google Scholar 

  • Singer, P.A., et al. 2004. Genomics and global health: A Report of the Genomics Working Group of the Science and Technology Task Force of the United Nations Millennium Project, 1–79. Toronto: University of Toronto, Joint Center for Bioethics. http://hdl.handle.net/10822/547743.

    Google Scholar 

  • Singh, S.P., et al. 2016. Gene therapy: Recent development in the treatment of various diseases. International Journal of Pharmaceutical, Chemical and Biological Sciences 6: 205–214.

    Google Scholar 

  • Song, M., Hwi-Won Lee, and Daehee Kang. 2014. The potential application of personalized preventive research. Japanese Journal of Clinical Oncology 44 (11): 1017–1024.

    Article  Google Scholar 

  • Takahashi, T., J.A. Luzum, M.R. Nicol, and P.A. Jacobson. 2020. Pharmacogenomics of COVID-19 therapies. NPJ Genomic Medicine 5 (35): 1–7.

    Google Scholar 

  • Tercyak, K.P., et al. 2012. Bridging the communication divide: A role for health psychology in the genomic era. Professional Psychology: Research and Practice 43 (6): 568–575.

    Article  Google Scholar 

  • Tikki, P. 2002. The impact of genomics on global health. American Journal of Public Health 92 (7): 1077–1079.

    Article  Google Scholar 

  • Tikki, P., and David Weatherall. 2002. Genomics and global health: Hype, reality, and a call for action in the developing and the developed world. BMJ: British Medical Journal 7345: 1051.

    Google Scholar 

  • Tremblay, J., and Pavel Hamet. 2013. Role of genomics on the path to personalized medicine. Metabolism Clinical and Experimental 62: S 2–S 5.

    Google Scholar 

  • Verma, Inder M., and Nikunj Somia. 1997. Gene therapy–Promises, problems and prospects. Nature 389 (6648): 239–242.

    Article  Google Scholar 

  • Vidyasagar, D. 2006. Global notes: The 10/90 gap disparities in global health research. Journal of Perinatology 26: 55–56.

    Article  Google Scholar 

  • Vyas, D.A., L.G. Eisenstein, and D.S. Jones. 2020. Hidden in plain sight—Reconsidering the use of race correction in clinical algorithms. New England Journal of Medicine 383: 874–882.

    Article  Google Scholar 

  • Williams, J.S., et al. 2016. Achieving equity in an evolving healthcare system: Opportunities and challenges. American Journal of Medical Science 351 (1): 33–43.

    Article  Google Scholar 

  • World Health Organization (WHO). 2002. Genomics and world health: Report of the advisory committee on health research, 1–254. Geneva: World Health Organization.

    Google Scholar 

  • ———. 2013. Global action plan for the prevention and control of noncommunicable diseases: 2013–2020. Geneva: WHO Press, World Health Organization.

    Google Scholar 

  • ———. 2018. Global health observatory (GHO) data. Retrieved from: http://www.who.int/gho/en/.

  • ———. 2021. Non communicable diseases. Retrieved from: http://www.who.int/en/news-room/fact-sheets/detail/noncommunicable-diseases.

  • Yeh, V.M., et al. 2020. Can precision medicine actually help people like me? African American and Hispanic perspectives on the benefits and barriers of precision medicine. Ethnicity & Disease 30 (Suppl 1): 149–158.

    Article  Google Scholar 

  • Zhou, Kaixin, et al. 2016. Pharmacogenomics in diabetes mellitus: Insights into drug action and drug discovery. Nature Reviews Endocrinology 12 (6): 337–346.

    Article  Google Scholar 

  • Zimmern, R.L. 2011. Genomics and individuals in public health practice: Are we luddites or can we meet the challenge? Journal of Public Health 33 (4): 477–482.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. California State University, San Bernardino, CA, USA

    Evangel Sarwar

Authors
  1. Evangel Sarwar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sarwar, E. (2023). Relevance of Precision Medicine in Public Health Genomics and Global Health Genomics. In: Global Perspectives on Precision Medicine. Advancing Global Bioethics, vol 19. Springer, Cham. https://doi.org/10.1007/978-3-031-28593-6_5

Download citation

Publish with us

Policies and ethics

Search

Navigation